EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways

BioMed Research International

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/9757309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 31.03.2026. Verfasst von BioMed Research International. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Research International, B. (2026). RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/9757309

Vancouver

Research International B. RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/9757309

BibTeX
@article{ResearchInternational2026,
  author = {Research International, BioMed},
  title = {RETRACTION: Apelin‐13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI‐3K/Akt and MAPK/Erk Signaling Pathways},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/9757309}
}
Kostenlos starten →